SNWV (SANUWAVE Health) LT-Debt-to-Total-Asset: 0.44 (As of Mar. 2026)

What is SANUWAVE Health LT-Debt-to-Total-Asset?

SANUWAVE Health SNWV -1.22% 38 LT-Debt-to-Total-Asset is 0.44 as of Mar. 2026. GuruFocus rates SNWV with a GF Score™ of 38/100 and a GF Value™ of $11.96 (Modestly Undervalued). The stock has 8 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. SANUWAVE Health's long-term debt to total assests ratio for the quarter that ended in Mar. 2026 was 0.44.

SANUWAVE Health's long-term debt to total assets ratio increased from Mar. 2025 (0.02) to Mar. 2026 (0.44). It may suggest that SANUWAVE Health is progressively becoming more dependent on debt to grow their business.

SANUWAVE Health (NAS:SNWV) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

SANUWAVE Health LT-Debt-to-Total-Asset Related Terms

SANUWAVE Health LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for SANUWAVE Health's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SANUWAVE Health LT-Debt-to-Total-Asset Chart

SANUWAVE Health Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.05

0.02

0.01

0.46

SANUWAVE Health Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.02	0.03	0.52	0.46	0.44

38GF Score

SANUWAVE Health Inc SNWV

LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

SANUWAVE Health LT-Debt-to-Total-Asset Calculation

SANUWAVE Health's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (A: Dec. 2025 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2025 )	/	Total Assets (A: Dec. 2025 )
	=	17.176	/	37.343
	=	0.46

SANUWAVE Health's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (Q: Mar. 2026 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2026 )	/	Total Assets (Q: Mar. 2026 )
	=	16.279	/	37.097
	=	0.44

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →

What does a LT-Debt-to-Total-Asset of 0.44 mean?

SANUWAVE Health (SNWV) has a LT-Debt-to-Total-Asset of 0.44 as of Mar. 2026. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on SANUWAVE Health and its competitors.

Is SANUWAVE Health's LT-Debt-to-Total-Asset too high?

SANUWAVE Health's current LT-Debt-to-Total-Asset is 0.44. Overall, SANUWAVE Health has a GF Score™ of 38/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.

How does SANUWAVE Health's LT-Debt-to-Total-Asset compare to RTGN and NNOX?

SANUWAVE Health's LT-Debt-to-Total-Asset of 0.44 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good LT-Debt-to-Total-Asset for a Medical Devices & Instruments company?

A good LT-Debt-to-Total-Asset depends on the Medical Devices & Instruments industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high LT-Debt-to-Total-Asset mean?

A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on SANUWAVE Health and its competitors. SANUWAVE Health's current LT-Debt-to-Total-Asset is 0.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is SANUWAVE Health stock overvalued right now?

Based on GuruFocus' analysis, SANUWAVE Health (SNWV) is currently considered Modestly Undervalued. The stock's GF Value™ is $11.96, compared to a current price of $10.50 — trading 12.2% below its estimated fair value. The current LT-Debt-to-Total-Asset is 0.44. SANUWAVE Health's overall GF Score™ is 38/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is LT-Debt-to-Total-Asset calculated?

LT-Debt-to-Total-Asset is calculated from a company's financial statements. For SANUWAVE Health (SNWV), the current LT-Debt-to-Total-Asset is 0.44 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SANUWAVE Health (SNWV) Overvalued in 2026?

Based on GuruFocus' analysis, SANUWAVE Health stock appears to be undervalued. The current stock price of $10.50 is trading 12.2% below its estimated GF Value™ of $11.96. GuruFocus considers SANUWAVE Health to be Modestly Undervalued.

Key valuation signals for SNWV:

LT-Debt-to-Total-Asset: 0.44
GF Value™: $11.96 vs. price of $10.50 (12.2% below fair value)
GF Score™: 38/100 with 8 warning signs

No single metric tells the full story. See the SNWV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SANUWAVE Health Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies RTGN NNOX LNSR SERA ECOR RPID OM POSC XTNT LUNG ABT SYK MDT BSX EW XTER:SHL GEHC DXCM XAMS:PHIA SZSE:300760

Address 9600 W. 76th Street, Suite 118, Eden Prairie, MN, USA, 55344

Website https://www.sanuwave.com

SANUWAVE Health Inc is a medical device company providing directed energy products into the wound care space. It is focused on the commercialization of its patented regenerative medicine utilizing noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. Sanuwave's patented, FDA-cleared, and commercialised product is the UltraMIST system, which is used to treat a variety of acute and chronic wounds using ultrasound technology. The company operates in one reportable segment, the design and sale of medical devices. Geographically, the company generates revenue mainly from the United States.

38GF Score

Get the complete analysis for SNWV

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.50

Price

$11.96

GF Value

View SNWV Analysis

See LT-Debt-to-Total-Asset data for all stocks →